文献速递血管炎

血浆丙酮酸激酶M2作为巨细胞动脉炎血管炎症标志物

Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本研究在巨细胞动脉炎(GCA)患者中检测血浆二聚体丙酮酸激酶M2(PKM2)水平,发现其升高并与CRP、ESR、钙卫蛋白和YKL-40相关,且经糖皮质激素治疗后下调;PKM2在血管炎症部位的巨噬细胞和T细胞中表达,循环PKM2水平与[18F]FDG-PET的平均靶本比评分相关。

要点

  • GCA患者血浆二聚体PKM2水平升高,并与CRP、ESR、钙卫蛋白和YKL-40相关。
  • 糖皮质激素治疗可下调升高的血浆PKM2水平。
  • 循环PKM2水平与[18F]FDG-PET平均靶本比评分相关。

核心结论

  • 升高的血浆PKM2水平反映GCA活动性血管炎症,可能有助于疾病诊断和疾病监测。

研究设计与样本

  • 对GCA患者炎症(n=12)和非炎症(n=4)颞动脉活检组织及非GCA患者(n=9)组织进行PKM2免疫组化检测。
  • 检测GCA患者(n=44)、年龄匹配健康对照(n=41)、转移性黑色素瘤患者(n=7)和感染对照(n=11)血浆二聚体PKM2水平。
  • 分析23例GCA患者的[18F]FDG-PET扫描,计算最大标准摄取值和靶本比。

主要发现

  • PKM2在GCA患者颞动脉活检组织中大量表达。
  • GCA患者血浆二聚体PKM2水平升高,并与CRP、ESR、钙卫蛋白和YKL-40水平相关。
  • 升高的血浆PKM2水平经糖皮质激素治疗后被下调。
  • 在血管炎症部位,PKM2在巨噬细胞和T细胞中均被检测到。
  • 循环PKM2水平与PET平均靶本比评分相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: GCA is a large vessel vasculitis in which metabolically active immune cells play an important role. GCA diagnosis is based on CRP/ESR and temporal artery biopsies (TABs), in combination with 18F-fluorodeoxyglucose ([18F]FDG)-PET/CT relying on enhanced glucose uptake by glycolytic macrophages. Here, we studied circulating Pyruvate Kinase M2 (PKM2), a glycolytic enzyme, as a possible systemic marker of vessel wall inflammation in GCA. METHODS: Immunohistochemical detection of PKM2 was performed on inflamed (n = 12) and non-inflamed (n = 4) TABs from GCA patients and non-GCA (n = 9) patients. Dimeric PKM2 levels were assessed in plasma of GCA patients (n = 44), age-matched healthy controls (n = 41), metastatic melanoma patients (n = 7) and infection controls (n = 11). CRP, ESR and macrophage markers calprotectin and YKL-40 were correlated with plasma PKM2 levels. To detect the cellular source of plasma PKM2 in tissue, double IF staining was performed on inflamed GCA TABs. [18F]FDG-PET scans of 23 GCA patients were analysed and maximum standard uptake values and target to background ratios were calculated. RESULTS: PKM2 is abundantly expressed in TABs of GCA patients. Dimeric PKM2 plasma levels were elevated in GCA and correlated with CRP, ESR, calprotectin and YKL-40 levels. Elevated plasma PKM2 levels were downmodulated by glucocorticoid treatment. PKM2 was detected in both macrophages and T cells at the site of vascular inflammation. Circulating PKM2 levels correlated with average target to background ratios PET scores. CONCLUSION: Elevated plasma PKM2 levels reflect active vessel inflammation in GCA and may assist in disease diagnosis and in disease monitoring.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Esen I, Jiemy WF, van Sleen Y, et al. Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis. Rheumatology (Oxford). 2022. PMID: 34730794. doi:10.1093/rheumatology/keab814

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。